Reply
暂无分享,去创建一个
M. Maurer | M. Safford | E. Levitan | M. Lachs | P. Goyal | Ligong Chen | Jerard Kneifati-Hayek | A. Archambault | Krisha Mehta | I. Diaz | James Hollenberg | Joseph T. Hanlon
[1] J. Hanlon,et al. Prescribing Patterns of Heart Failure-Exacerbating Medications Following a Heart Failure Hospitalization. , 2019, JACC. Heart failure.
[2] A. Levin,et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. , 2019, The lancet. Diabetes & endocrinology.
[3] Akshay S. Desai,et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. , 2019, The New England journal of medicine.
[4] B. Ky,et al. Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association. , 2016, Circulation.
[5] M. Klugar,et al. Effectiveness of β-blockers in physically active patients with hypertension: protocol of a systematic review , 2016, BMJ Open.
[6] M. Tinetti,et al. Potential Therapeutic Competition in Community-Living Older Adults in the U.S.: Use of Medications That May Adversely Affect a Coexisting Condition , 2014, PloS one.
[7] D. Kass,et al. Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction , 2006, Circulation.